ended of 30 June 2017 (Revised) Attention: Directors and Manager The Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results

Samutprakarn, Samutprakarn 10280, Thailand Tel. 66 2323 1085..96 Fax. 66 2323 9283 (Translation) August 10, 2017 Subject: Management Discussion and Analysis (MD&A) of Q2/2017 To: Director and manager The Stock

for Q2/2017 To : Director and General Manager The Stock Exchange of Thailand Eureka Design Public Company Limited and its subsidiaries (“the Group”) would like to clarify the changes in excess of 20% in

and General Manager The Stock Exchange of Thailand Eureka Design Public Company Limited and its subsidiaries (“the Group”) would like to clarify the changes in excess of 20% in the Group’s operating

บริษัท สำนักกฎหมายธรรมนิติ จำกัด Page 1 of 2 No. NDR006/2018 Date: 23 February 2018 Subject Management Discussion and Analysis (MD&A) Report for Q4/2017 Attention Directors and Manager, The Stock

MDA 2560ENG.1 Final v.1 Page 1 of 2 No. NDR006/2018 Date: 23 February 2018 Subject Management Discussion and Analysis (MD&A) Report for the year 2017 (Revise) Attention Directors and Manager, The

: Director and General Manager The Stock Exchange of Thailand Eureka Design Public Company Limited and its subsidiaries (“the Group”) would like to clarify the changes in excess of 20% in the Group’s operating

, Samutprakarn 10280, Thailand Tel. 66 2323 1085..96 Fax. 66 2323 9283 (Translation) 14 May 2019 Subject: Management Discussion and Analysis (MD&A) of Q1/2019 To: Director and manager The Stock Exchange of

and General Manager The Stock Exchange of Thailand Eureka Design Public Company Limited and its subsidiaries (“the Group”) would like to clarify the changes in excess of 20% in the Group’s operating

and General Manager The Stock Exchange of Thailand Eureka Design Public Company Limited and its subsidiaries (“the Group”) would like to clarify the changes in excess of 20% in the Group’s operating